Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Clofazimine induced pigmentation in leprosy patches.

Chavhan S, Jawade S. The Pan African medical journal. 2022;
Download PDF
Publication

An evidence and reasoning based differential diagnosis of a case of leprosy reinfection from reaction and relapse.

Kumar V, Arora M, Gupta V, et al. Indian journal of medical microbiology. 2022;
Publication

Histoid hansen's with transepidermal elimination: Five cases.

Babanrao S, Tomar S, Wankhade V, et al. International journal of mycobacteriology. 2022; 11 (2) : 217-221.
Download PDF
Publication

Effective amelioration of lucio phenomenon with adjuvant tofacitinib therapy in a patient with dual infection of M. leprae and M. lepromatosis : A case report from India.

Patel NH, Padhiyar JK, Patel KA, et al. Microbiology Society. 2022;
Download PDF
Publication

Comment on "Multibacillary leprosy unmasked by COVID-19 vaccination".

Hanumanthu V, Narang T, Dogra S. JAAD case reports. 2022;
Download PDF
Publication

Lucio phenomenon in a case of lepromatous leprosy

Zambare U, Musaddique Ansari S, Gupta A, et al. Medknow. Medical Journal of Dr. D.Y. Patil Vidyapeeth. 2022;
Download PDF
Publication

Clinical profile of patients with pure neuritic leprosy: 20 years’ experience at a tertiary referral centre from North India

Bhalla M, Poonia K, Jain S, et al. Lepra. Leprosy Review. 2022; 93 (2) : 131-137.
Download PDF
Publication

Understanding leprosy reactions and the impact on the lives of people affected: An exploration in two leprosy endemic countries.

Putri A, de Sabbata K, Agusni R, et al. PLoS neglected tropical diseases. 2022; 16 (6) : e0010476.
Download PDF
Publication

A study of histopathological spectrum of leprosy at tertiary care hospital

Patel PR, Patel K, Vyas J, et al. IP Innovative Publication Pvt Ltd. Indian Journal of Pathology and Oncology. 2022; 9 (1) : 16-20.
Download PDF
Publication

Correction: The role of perceptions and knowledge of leprosy in the elimination of leprosy: A baseline study in Fatehpur district, northern India.

Noordende A, Korfage I, Lisam S, et al. PLoS neglected tropical diseases. 2022; 16 (6) : e0010519.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 42
  • Next page ››
Subscribe to India

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD